Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced to support cartilage function and joint health; CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. It has a research agreement with Stanford University School of Medicine for pre-clinical and clinical research on necrotizing enterocolitis and irritable bowel syndrome. The company was founded in 2000 and is headquartered in Ålesund, Norway.

Ms. Angelika  Florvaag

Chief Quality Officer

Mr. James  Berger

Chief Commercial Officer

Ms. Christel Elise Kanli

Chief Financial Officer & Chief Operating Officer

Dr. Crawford Linden Alexander Currie

Head of Medical R&D and Director

Dr. Bomi  Framroze

Chief Scientific Officer

Mr. Jon Olav Odegard

Chief Executive Officer

Biotekniikka

Hofseth BioCare ASA

Hofseth BioCare ASA Johtamisrakenne

Johdon tiedot